Lonza
Lonza offers Biologics analytical development, characterization and GMP testing. This is the analytical service business of an integrated CRO/CDMO.
Corporate information
- Company entity
- Lonza
- Headquarters / principal office
- Headquarters city not independently verified; see the country/network tags.
- Founded
- 1897 ↗
- Ownership / capital status
- Publicly tradedPublicly listed; see issuer disclosures ↗
- Official corporate reference
- https://lonza.com/ ↗
- LinkedIn company page
- LinkedIn ↗ ↗
Profile review: 2026-11-05 · Fields retain their individual source dates. Undisclosed values are not zero; early or historical events do not establish the latest financing. Awards and acquisitions are distinguished from equity rounds.
Start with public sources and capability boundaries; company claims are not independent certification.
Ask AI ↗Public evidence snapshot
Oral drug product services include preformulation, dosage form development, bioavailability enhancement, and clinical-to-commercial supply, with disclosed ASD and dissolution development services.
This profile is a research snapshot, not a company endorsement. Check original sources for current information.
Original sources
- Drug Product Formulation and Development
- Lonza — LinkedIn
- Lonza官方简介：1897成立，SIX上市及SGX第二上市
- Primary corporate profile / legal-entity disclosure